Respiratory syncytial virus (RSV): over 60 years of research but still so many unanswered questions

被引：0
|
作者：
Drysdale, Simon B. B. [2 ,3 ]
Broadbent, Lindsay [1 ]
机构：
[1] Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, England
[2] St Georges Univ Hosp NHS Fdn Trust, Dept Paediat, London, England
[3] St Georges Univ London, Ctr Neonatal & Paediat Infect, London, England
来源：
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE | 2023年 / 10卷
关键词：
INFECTIONS; BURDEN;
D O I：
10.1177/20499361231159991
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
    Collins, Peter L.
    Melero, Jose A.
    VIRUS RESEARCH, 2011, 162 (1-2) : 80 - 99
  • [12] Respiratory syncytial virus (RSV) companionship with rhinovirus (RV) in children with respiratory tract infection (RTV) under five years
    Shuwaikh, Elaph Madallah
    Jafar, Nihad Abdul-Hussain
    Ahmed, Sana Sauod
    MALAYSIAN JOURNAL OF MICROBIOLOGY, 2024, 20 (06) : 218 - 221
  • [13] A Respiratory Syncytial Virus (RSV) Prefusion F Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥60 Years of Age ( YOA)
    Ison, M.
    Papi, A.
    Langley, J.
    Lee, D.
    Leroux-Roels, I
    Martinon-Torres, F.
    Schwarz, T.
    van Zyl-Smit, R.
    Dezutter, N.
    de Schrevel, N.
    Fissette, L.
    David, M.
    Van Der Wielen, M.
    Kostanyan, L.
    Hulstrom, V
    PNEUMOLOGIE, 2023, 77 : S10 - S11
  • [14] Epidemiology of Respiratory Syncytial Virus (RSV) in Adults and Children With Medically Attended Acute Respiratory Illness Over Three Seasons
    Begley, Katherine M.
    Leis, Aleda M.
    Petrie, Joshua G.
    Truscon, Rachel
    Johnson, Emileigh
    Lamerato, Lois E.
    Wei, Melissa
    Monto, Arnold S.
    Martin, Emily T.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 1039 - 1045
  • [15] Evolution of Human Respiratory Syncytial Virus (RSV) over Multiple Seasons in New South Wales, Australia
    Di Giallonardo, Francesca
    Kok, Jen
    Fernandez, Marian
    Carter, Ian
    Geoghegan, Jemma L.
    Dwyer, Dominic E.
    Holmes, Edward C.
    Eden, John-Sebastian
    VIRUSES-BASEL, 2018, 10 (09):
  • [16] Quantifying the prevalence and determinants of respiratory syncytial virus (RSV) vaccine hesitancy in US adults aged 60 or older
    Motta, M.
    Callaghan, T.
    Padmanabhan, M.
    Ross, J.
    Gargano, L. M.
    Bowman, S.
    Yokum, D.
    PUBLIC HEALTH, 2025, 238 : 3 - 6
  • [17] DEVELOPMENT OF RESEARCH QUESTIONS ON THE EFFICACY OF RIBAVIRIN IN RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS - DISCUSSION
    MARKS, MI
    HARRISON, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (09) : S120 - S121
  • [18] DEVELOPMENT OF RESEARCH QUESTIONS ON THE SAFETY OF RIBAVIRIN IN THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS
    HARRISON, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (09) : S99 - S99
  • [19] PRIORITIZING RESEARCH QUESTIONS ON THE SAFETY OF RIBAVIRIN IN THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS
    KOREN, G
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (09) : S122 - S123
  • [20] Efficacy of one dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in adults ≥60 years of age persists for 2 RSV seasons
    Ison, M.
    Mangan, N.
    Papi, A.
    Langley, J.
    Lee, D.
    Leroux-Roels, I
    Martinon-Torres, F.
    Schwarz, T.
    Zyl-Smit, R.
    Cuadripani, S.
    Dezutter, N.
    Gruselle, O.
    Fissette, L.
    David, M.
    Olivier, A.
    Wielen, M.
    Descamps, D.
    RESPIROLOGY, 2024, 29 : 104 - 105
12345